{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:40:06Z","timestamp":1792615206832,"version":"4.5.0"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016226","name":"Accuray Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011676","name":"Elekta AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eururo.2026.09.030","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:24:05Z","timestamp":1792524245000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Response to \u201cFive-Year Patient-reported Outcomes After SBRT for Prostate Cancer: A Benchmark for Radiotherapy, but How Far Across Modalities?\u201d Pierre Blanchard, Chiara Sighinolfi, Mario Terlizzi, et al. Eur Urol. In press. http:\/\/dx.doi.org\/10.1016\/j.eururo.2026.07.023"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1016-9841","authenticated-orcid":false,"given":"Sian","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busola","family":"Adebusoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison C.","family":"Tree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2026.09.030_b0005","doi-asserted-by":"crossref","unstructured":"Blanchard P, Sighinolfi C, Terlizzi M, Rocco B. Five-year patient-reported outcomes after SBRT for prostate cancer: a benchmark for radiotherapy, but how far across modalities? Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2026.07.023.","DOI":"10.1016\/j.eururo.2026.07.023"},{"key":"10.1016\/j.eururo.2026.09.030_b0010","doi-asserted-by":"crossref","unstructured":"Cooper S, Patel J, Moore C, et al. Patient-reported outcomes after prostate stereotactic body radiotherapy at 5 yr: results from the PACE-B trial. Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2026.05.034.","DOI":"10.1016\/j.eururo.2026.05.034"},{"key":"10.1016\/j.eururo.2026.09.030_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.euros.2024.05.003","article-title":"Urinary and sexual impact of robotic radical prostatectomy: reporting of patient-reported outcome measures in the first year after radical prostatectomy in a contemporary multicentre cohort in the United Kingdom","volume":"64","author":"Bridge","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.eururo.2026.09.030_b0020","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"N Engl J Med"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826024413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826024413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:48:03Z","timestamp":1792612083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283826024413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":4,"alternative-id":["S0302283826024413"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2026.09.030","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Response to \u201cFive-Year Patient-reported Outcomes After SBRT for Prostate Cancer: A Benchmark for Radiotherapy, but How Far Across Modalities?\u201d Pierre Blanchard, Chiara Sighinolfi, Mario Terlizzi, et al. Eur Urol. In press. http:\/\/dx.doi.org\/10.1016\/j.eururo.2026.07.023","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2026.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier B.V. on behalf of European Association of Urology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}